Format

Send to

Choose Destination
See comment in PubMed Commons below
Radiology. 2011 May;259(2):329-45. doi: 10.1148/radiol.11090563.

Early diagnosis of ovarian carcinoma: is a solution in sight?

Author information

1
Department of Radiology, Bio-X Program, Stanford University School of Medicine, 318 Campus Dr, Room E150, Stanford, CA 94305, USA.

Abstract

Ovarian cancer is the most lethal of the gynecologic malignancies. Because ovarian cancer symptoms are subtle and nonspecific, the diagnosis is often delayed until the disease is well advanced. Overall 5-year survival is a rather dismal 50% but can be improved to greater than 90% if the disease is confined to the ovary at the time of diagnosis (generally in fewer than 25% of patients). Effective screening tools are currently not available. Owing to the rather low incidence of the disease in the general population, potential screening tests must provide very high specificity to avoid unnecessary interventions in false-positive cases. This article reviews currently available serum biomarkers and imaging tests for the early detection of ovarian cancer and provides an outlook on the potential improvements in these noninvasive diagnostic tools that may lead to successful implementation in a screening program.

SUPPLEMENTAL MATERIAL:

http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11090563/-/DC1.

PMID:
21502390
DOI:
10.1148/radiol.11090563
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center